Bowden R - Search Results

1

Effects of ribose supplementation prior to and during intense exercise on anaerobic capacity and metabolic markers.

Kerksick C, Rasmussen C, Bowden R, Leutholtz B, Harvey T, Earnest C, Greenwood M, Almada A, Kreider R. Kerksick C, et al. Among authors: bowden r. Int J Sport Nutr Exerc Metab. 2005 Dec;15(6):653-64. doi: 10.1123/ijsnem.15.6.653. Int J Sport Nutr Exerc Metab. 2005. PMID: 16521849 Clinical Trial.

2

Effects of calcium pyruvate supplementation during training on body composition, exercise capacity, and metabolic responses to exercise.

Koh-Banerjee PK, Ferreira MP, Greenwood M, Bowden RG, Cowan PN, Almada AL, Kreider RB. Koh-Banerjee PK, et al. Nutrition. 2005 Mar;21(3):312-9. doi: 10.1016/j.nut.2004.06.026. Nutrition. 2005. PMID: 15797672 Free article. Clinical Trial.

3

Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men.

Campbell B, Roberts M, Kerksick C, Wilborn C, Marcello B, Taylor L, Nassar E, Leutholtz B, Bowden R, Rasmussen C, Greenwood M, Kreider R. Campbell B, et al. Among authors: bowden r. Nutrition. 2006 Sep;22(9):872-81. doi: 10.1016/j.nut.2006.06.003. Nutrition. 2006. PMID: 16928472 Clinical Trial.

4

Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts.

Bowden RG, Wilson RL, Gentile M, Ounpraseuth S, Moore P, Leutholtz BC. Bowden RG, et al. J Ren Nutr. 2007 Mar;17(2):126-31. doi: 10.1053/j.jrn.2006.07.009. J Ren Nutr. 2007. PMID: 17321952 Clinical Trial.

5

Effects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women.

Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A, Milnor P, Magrans T, Bowden R, Ounpraseuth S, Thomas A, Kreider RB. Henderson S, et al. Among authors: bowden r. J Int Soc Sports Nutr. 2005 Dec 9;2(2):54-62. doi: 10.1186/1550-2783-2-2-54. J Int Soc Sports Nutr. 2005. PMID: 18500958 Free PMC article.

6

Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.

Bowden RG, Jitomir J, Wilson RL, Gentile M. Bowden RG, et al. J Ren Nutr. 2009 Jul;19(4):259-66. doi: 10.1053/j.jrn.2009.01.030. J Ren Nutr. 2009. PMID: 19539180 Clinical Trial.

7

Systemic glucose level changes with a carbohydrate-restricted and higher protein diet combined with exercise.

Bowden RG, Lanning BA, Doyle EI, Slonaker B, Johnston HM, Scanes G. Bowden RG, et al. J Am Coll Health. 2007 Sep-Oct;56(2):147-52. doi: 10.3200/JACH.56.2.147-152. J Am Coll Health. 2007. PMID: 17967760 Clinical Trial.

8

Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.

Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Beavers KM, et al. Nephrology (Carlton). 2008 Jun;13(4):284-8. doi: 10.1111/j.1440-1797.2008.00934.x. Epub 2008 Mar 5. Nephrology (Carlton). 2008. PMID: 18331436 Clinical Trial.

9

Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.

Bowden RG, Wilson RL, Deike E, Gentile M. Bowden RG, et al. Nutr Clin Pract. 2009 Aug-Sep;24(4):508-12. doi: 10.1177/0884533609335376. Epub 2009 May 21. Nutr Clin Pract. 2009. PMID: 19461006 Clinical Trial.

10

Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.

Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Beavers KM, et al. J Ren Nutr. 2009 Nov;19(6):443-9. doi: 10.1053/j.jrn.2009.06.005. Epub 2009 Sep 12. J Ren Nutr. 2009. PMID: 19748798 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters